LUV Systems Announces Initial Low-UVC Patent Filings Covering Broad Disinfection Applications

RANCHO PALOS VERDES, CA (July 10, 2020) — LUV Systems, Inc. today announced that the U.S. Patent & Trademark Office has recorded multiple utility patent applications representing the company’s initial portfolio of proprietary low-wavelength ultraviolet (UVC) technologies. The filings cover six novel inventions designed to enable continuous disinfection of air and surfaces in occupied environments without direct human exposure.

These filings establish a foundational intellectual property position for LUV Systems across a broad range of high-demand applications, including:

• Indoor environments such as healthcare and long-term care facilities, restaurants, offices, schools, gyms, and transportation systems;
• High-touch commercial settings, including retail transaction points, event venues, ATMs, touchscreens, elevators, and fuel stations; and
• Personal-use devices, including handheld and three-dimensional disinfection solutions.

Neeraj Chaudhary, Business Analyst at LUV Systems, highlighted the strategic importance of the filings:  “These patent applications form the basis of a scalable and diversified product portfolio targeting both consumer and commercial markets. They position LUV Systems to address the growing, long-term demand for improved indoor air quality and continuous pathogen control across multiple sectors.”

The company’s technology platform is supported by a growing body of third-party research indicating that low-wavelength UVC, when applied at specific wavelengths and intensities, can achieve greater than 99.9% inactivation of SARS-CoV-2 and other pathogens in both air and surface applications. UV disinfection has been used for more than a century across healthcare, laboratory, and water treatment settings, underscoring its established efficacy and broad market acceptance.

Emerging scientific research further suggests that certain low-UVC wavelengths, particularly at or below 222 nanometers, may enable effective pathogen inactivation while minimizing impact on mammalian tissues under controlled exposure conditions. This supports the potential for safe operation in occupied environments and expands the addressable market for continuous disinfection solutions.

LUV Systems’ product strategy is built on three core value drivers:

• Proven Effectiveness against a broad range of airborne pathogens and allergens
• Engineered Safety for use in occupied environments, including around people and pets; and
• Affordability to enable widespread adoption across consumer and commercial markets.

To support performance and differentiation, LUV Systems has developed a proprietary dosing algorithm that correlates surface viral inactivation data with effective indoor air disinfection rates, enhancing the predictability and scalability of its solutions.

With its initial patent filings in place, LUV Systems is advancing product development and positioning its technology platform for commercialization across large, diversified global markets.